Study examines global availability of treatment involving transplantation of blood stem cells
An examination of the world-wide use of hematopoietic stem cell transplantation (HSCT), which involves transplantation of blood stem cells derived from the bone marrow or blood, finds that there are significant differences in transplant rates between countries and continental regions by indication and donor type, and that HSCT is most frequently used in countries with higher gross national incomes and governmental health care expenditures, according to a study in the April 28 issue of JAMA.
[Read the full article here]Related News:
Study Examines Global Use And Availability Of Treatment Involving Transplantation Of Blood Stem Cells
Hematopoietic Stem Cell Transplantation: A Global Perspective [Original Contribution]
Women with breast cancer may benefit from autologous stem cell transplantation